<html>
<head>

<title>Human Foreskin Fibroblasts</title>


<meta name="Author" 
content="John A. Erickson">

<meta name="description" 
content="Titles of medical journal articles documenting the use of
human foreskins in medical, pharmaceutical, and other commercial
enterprises."> 

<meta name="keywords" 
content="foreskins for sale, human fibroblasts, human foreskin
fibroblasts, Dermagraft, Advanced Tissue Sciences, Biotech, 
Organogenesis">


</head>

<body>

<center>

<b><big>Medical Journal Articles from 1969 to 1998 Documenting
<p><big>The Use of Human Foreskins in Medical,
<br>Pharmaceutical, and Other Commercial Enterprises</big></big></b>
<p>
<br>
</center>

A universal MEDLINE search on 25 April 1998 using the key words
"Foreskin Fibroblasts" (the term used for harvested foreskins after 
they are processed for sale) yielded 471 articles. The articles
with "human foreskin fibroblasts" in their titles are listed below.
<p>
<br>

PGE1 but not PGI2 desensitizes the PGI2 receptor-adenylate cyclase
complex in human foreskin fibroblasts.
Gorman-RR; Hopkins-NK.
Adv-Prostaglandin-Thromboxane-Res. 1980; 8: 1717-21.
<P>

Agonist-specific desensitization of PGI2-stimulated cyclic AMP
accumulation by PGE1 in human foreskin fibroblasts.
Gorman-RR; Hopkins-NK.
Prostaglandins. 1980 Jan; 19(1): 2-16.
<P>

Inhibition of androgen binding in human foreskin fibroblasts by
antiandrogens.
Brown-TR; Rothwell-SW; Sultan-C; Migeon-CJ.
Steroids. 1981 Jun; 37(6): 635-48.
<P>

Growth of human foreskin fibroblasts in a serum-free, defined medium
without platelet-derived growth factor.
Weinstein-R; Hoover-GA; Majure-J; van-der-Spek-J; Stemerman-MB; Maciag-T.
J-Cell-Physiol. 1982 Jan; 110(1): 23-8.
<P>

Characterization of steroid binding specificity of the androgen
receptor in human foreskin fibroblasts.
Cunningham-GR; Lobl-TJ; Cockrell-C; Shao-TC; Tindall-DJ.
Steroids. 1983 May; 41(5): 617-26.
<P>

Inhibition of androgen metabolism and binding by a liposterolic
extract of "Serenoa repens B" in human foreskin fibroblasts.
Sultan-C; Terraza-A; Devillier-C; Carilla-E; Briley-M; Loire-C;
Descomps-B.
J-Steroid-Biochem. 1984 Jan; 20(1): 515-9.
<P>

Preferential binding of benzo[a]pyrene diol epoxide to the linker DNA
of human foreskin fibroblasts in S phase in the presence of benzamide.
Kurian-P; Jeffrey-AM; Milo-GE.
Proc-Natl-Acad-Sci-U-S-A. 1985 May; 82(9): 2769-73.
<P>

Cryptic urokinase binding sites on human foreskin fibroblasts.
Bajpai-A; Baker-JB.
Biochem-Biophys-Res-Commun. 1985 Dec 17; 133(2): 475-82.
<P>

Intracellular modification of 125I-labeled epidermal growth factor by
normal human foreskin fibroblasts.
Schaudies-RP; Savage-CR Jr.
Endocrinology. 1986 Feb; 118(2): 875-82.
<P>

Specific BPDE I modification of replicating and parental DNA from
early S phase human foreskin fibroblasts.
Ribovich-ML; Kurian-P; Milo-GE.
Carcinogenesis. 1986 May; 7(5): 737-44.
<P>

The influence of 4-hydroxy-4-androstene-3,17-dione on androgen
metabolism and action in cultured human foreskin fibroblasts.
Hsiang-YH; Berkovitz-GD; Brown-TR; Migeon-CJ; Brodie-AM.
J-Steroid-Biochem. 1987 Jan; 26(1): 131-5.
<P>

Growth control of human foreskin fibroblasts and inhibition of
extracellular sialidase activity by 2-deoxy-2,3-dehydro-N-acetylneuraminic
acid.
Usuki-S; Hoops-P; Sweeley-CC.
J-Biol-Chem. 1988 Aug 5; 263(22): 10595-9.
<P>

Cultured human foreskin fibroblasts produce a factor that stimulates
their growth with properties similar to basic fibroblast growth factor.
Story-MT.
In-Vitro-Cell-Dev-Biol. 1989 May; 25(5): 402-8.
<P>

Epidermal growth factor stimulates phosphatidylinositol turnover in
human foreskin fibroblasts without activation of protein kinase C.
Thompson-DM; Thomas-C; Kinsey-G.
J-Cell-Biochem. 1989 Dec; 41(4): 201-5.
<P>

Quantitative evaluation of the effects of human carcinogens and
related chemicals on human foreskin fibroblasts.
Kurian-P; Nesnow-S; Milo-GE.
Cell-Biol-Toxicol. 1990 Apr; 6(2): 171-84.
<P>

Laminin on Toxoplasma gondii mediates parasite binding to the beta 1
integrin receptor alpha 6 beta 1 on human foreskin fibroblasts and Chinese
hamster ovary cells.
Furtado-GC; Cao-Y; Joiner-KA.
Infect-Immun. 1992 Nov; 60(11): 4925-31.
<P>

Avian sarcoma virus RNA synthesis, RNA splicing and virus production
in human foreskin fibroblasts: effect of co-infection with human
cytomegalovirus.
Knight-JB; Stinski-MF; Stoltzfus-CM.
J-Gen-Virol. 1993 Dec; 74 (Pt 12): 2629-36.
<P>

Subcellular localization of annexins in human foreskin fibroblasts.
Barwise-JL; Walker-JH.
Biochem-Soc-Trans. 1995 Feb; 23(1): 35S.
<P>

Annexins II, IV, V and VI relocate in response to rises in
intracellular calcium in human foreskin fibroblasts.
Barwise-JL; Walker-JH.
J-Cell-Sci. 1996 Jan; 109 ( Pt 1): 247-55.
<P>

Bradykinin induces tyrosine phosphorylation in human foreskin
fibroblasts and 293 cells transfected with rat B2 kinin receptor.
Tippmer-S; Bossenmaier-B; Haring-H.
Eur-J-Biochem. 1996 Mar 15; 236(3): 953-9.
<P>

Haemophilus ducreyi hemolysin acts as a contact cytotoxin and damages
human foreskin fibroblasts in cell culture.
Alfa-MJ; DeGagne-P; Totten-PA.
Infect-Immun. 1996 Jun; 64(6): 2349-52.
<P>

An isogenic haemolysin-deficient mutant of Haemophilus ducreyi lacks
the ability to produce cytopathic effects on human foreskin fibroblasts.
Palmer-KL; Goldman-WE; Munson-RS Jr.
Mol-Microbiol. 1996 Jul; 21(1): 13-9.
<P>

Subcellular localization of annexin V in human foreskin fibroblasts:
nuclear localization depends on growth state.
Barwise-JL; Walker-JH.
FEBS-Lett. 1996 Sep 30; 394(2): 213-6.
<P>

Attachment of Haemophilus ducreyi to human foreskin fibroblasts
involves LOS and fibronectin. Alfa-MJ; DeGagne-P. 
Microb-Pathog. 1997 Jan; 22(1): 39-46.

<hr>

<a href="index.htm">Return to opening page</a>

</body>
</html>